Current Trends and Future Outlook of the Canada Enteral Nutrition Market: A Comprehensive Analysis

Canada Enteral Nutrition Market: Key Insights

Canada enteral nutrition market is expected to grow from CA$ 514.33 million in 2023 to CA$ 817.11 million by 2031; it is estimated to record a CAGR of 6.0% during 2023–2031. Key factors driving the Canada enteral nutrition market growth include the surge in prevalence of cachexia and related disorders and rise in prevalence of gastrointestinal diseases. Further, the specific formulations and plant-based nutrition products is expected to bring new Canada enteral nutrition market trends in the coming years.

Surge in Prevalence of Cachexia and Related Disorders Drives Canada Enteral Nutrition Market Growth:

The Canadian Mental Health Association celebrates Eating Disorder Awareness Week by wearing purple on February 1, Every year. Cachexia, anorexia, and eating disorders are related in a way that highlights the complex interactions between physiological, psychological, and metabolic aspects. Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. In people with underlying medical disorders, anorexia (a chronic lack of appetite or reduced food intake) may play a role in the onset or aggravation of cachexia. Reduced calorie intake in anorexic patients further hampers their metabolic capacity to preserve muscle mass, store vital nutrients, and attain general metabolic equilibrium, subsequently accelerating the development of cachexia. According to the National Initiative for Eating Disorders, as of 2023, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), avoidance restrictive food intake disorder (ARFID), and otherwise specified feeding and eating disorder (OSFED) affect approximately 1 million Canadians who have been diagnosed with an eating disorder. Additionally, according to the Canadian Community Health Survey, 1.8% of women aged 65 or more and 2.6% of women from the age group of 50–64 reported having an eating disorder. Thus, with the burgeoning incidence of cachexia, anorexia, and eating disorders—collaborative efforts, awareness initiatives, and implementation of tailored interventions that target both the physical and psychological aspects of the abovementioned conditions support the Canada enteral nutrition market growth.

Use of Next-Generation Technologies to Ensure Proper Feeding Routines Creates Opportunities for Canada Enteral Nutrition Market

In enteral feeding, it is important to calculate the daily and cumulative energy balance of patients, which helps doctors tailor the feeding routing according to their needs along with decreasing the morbidity and mortality risks. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating patients’ daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficits and monitor the energy balance. The next-generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy levels and nutrient (proteins and vitamins) deficits. A similar approach could help tackle deficit challenges in the post-ICU period. The implementation of next-generation technology-based tools in critical stages could help to ensure constant measurement, monitoring, and achievement of the nutritional plan and goals. In addition, data collected by wearable devices, including data from sensors continuously measuring physical activity and glucose levels, can be integrated with electronic health records (EHR).

The growing fields of metabolomics and proteomics hold the potential to enable the assessment of nutritional status, determining the appropriate adjustments of nutrient mix, and monitoring progress through various stages of illness. Therefore, the use of AI, predictive analytics, metabolomics and proteomics, and several other next-generation technologies ensuring proper feeding routines are expected to create lucrative growth opportunities for the Canada enteral nutrition market during the forecast period.

Canada Enteral Nutrition Market: Segmental Overview

Based on disease indication, the orthopedic disorders segment held the largest Canada enteral nutrition market share in 2023. The Cardiovascular disorders segment is anticipated to register the highest CAGR during 2023–2031.

Based on formula type, the companion animals segment held a larger market share in 2023. The standard formulas segment is anticipated to register a higher CAGR from 2023 to 2031 and the same segment held a larger Canada enteral nutrition market share.

Based on route of administration, the oral segment held a larger share of the Canada enteral nutrition market in 2023 and the same segment is anticipated to register a higher CAGR during 2023–2031.

In terms of end user, the long-term care facilities segment is anticipated to account for a significant market share during 2023–2031.

Canada Enteral Nutrition Market: Competitive Landscape and Key Developments

Nestle SA, Abbott Laboratories, Fresenius Medical Care AG & Co KgaA, Koninklijke DSM NV, and B Barun SE are among the prominent players profiled in the Canada enteral nutrition market report. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.

Contact Us: [email protected]